@aestheticsgroup
@aestheticsjournaluk
Aesthetics
aestheticsjournal.com
Skincare
Talk #Aesthetics Follow us on Twitter @aestheticsgroup and Instagram @aestheticsjournaluk
#Celebration BAAPS @BAAPSMedia We’re 40 this year! We’re extremely grateful to those who have served the Association over the years to make #BAAPS what it is today
#Training Dr Ash Labib @ashlabib It’s the end of three successful visits to Dublin! 6 masterclasses, 33 delegates advanced Volux training and lots more! Thanks to the amazing team @kyram90 for their support, I thoroughly enjoyed it! #AllerganUK #ALMedicalAcademy #Teamwork Facial Aesthetics @facial.aesthetic.courses We hope everyone has had a fantastic summer. We pride ourselves on what an experienced, hard-working team we have at Facial Aesthetics and decided to celebrate that yesterday by having a day out at the Edinburgh Fringe! #Knowledge Dr Olha Vorodyukhina @dr_olha I love working with these professionals! Here’s us at the Cosmetic Courses experts meeting, the Nottingham team! Sharing knowledge is the key to success. #Mentorship #Training #ExpertNurse Lou Sommereux @lousommereux BACN educational working party in London this afternoon. Re-visiting and rewriting the BACN RCN-accredited competencies! #EducationalPathway
SkinCeuticals releases pigmentation serum Cosmeceutical company SkinCeuticals has released a new serum that aims to address visible discolouration in skin to deliver a brighter, more even tone. The Discoloration Defense Serum is formulated to address pigmentation triggered by inflammatory processes in the skin such as melasma caused by hormonal changes and acne scarring, according to SkinCeuticals. The product contains 1.8% tranexamic acid, 5% niacinamide, and 5% 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES). A 12-week single-centre clinical study looked at 63 females, aged 26-60, with Fitzpatrick I-IV and mild to moderate facial pigmentation, including melasma, post-inflammatory hyperpigmentation and hyperpigmentation, who applied Discoloration Defense Serum to the face twice a day in conjunction with a sunscreen. Patients demonstrated a statistically significant reduction in the appearance of post-inflammatory discolouration and uneven skin tone, including a 41% average reduction in the appearance of melasma, according to the company. Dr Alexis Granite, a consultant dermatologist practising at the Cadogan Clinic and Mallucci London, said, “In clinic, I use the serum as a complement to professional discolouration treatments, such as chemical peels. I also recommend Discoloration Defense Serum for daily home use by patients whom wish to break the pigmentation cycle and take a long-term approach to the care of their skin to provide a clearer, more revitalised complexion.” Dermal fillers
New MD Code injection techniques to launch Plastic surgeon Mr Mauricio de Maio is unveiling two new dermal filler injection techniques to treat the chin and jawline, in conjunction with global pharmaceutical company Allergan. The new MD Codes – the 7-POINT-SHAPE for women and 9-POINT SHAPE for men – include a combination of Juvéderm dermal filler products and treatment points for the cheek, chin and jawline for results lasting 18-24 months. According to Allergan, both protocols feature Juvéderm Volux, a structural facial filler and the latest innovation in the Juvéderm range designed to sculpt the chin and jawline, and Juvéderm Voluma with lidocaine. To launch the new MD Codes, Mr de Maio will host an immersive digital tutorial webinar to medical professionals through the Allergan Medical Institute on September 12. The session will introduce the new protocols live, as well as introduce Juvéderm Volux, demonstrating how and when to use this product alongside Juvéderm Voluma with lidocaine to revitalise the lower face.
Reproduced from Aesthetics | Volume 6/Issue 10 - March 2019
